[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100529339":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":25,"responsibleParty":58,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":10,"enrollmentInfo":71,"targetDuration":10,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":80,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"No Delirium Severity",null,"Patients who did not experience a level of delirium severity (subsyndromal, mild, moderate, severe)",{"label":13,"type":10,"description":14,"interventionNames":10},"Delirium Severity","Patients who did experience a level of delirium severity (subsyndromal, mild, moderate, severe)",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Heidi Lindroth, PH.D. R.N.","CONTACT","507-284-3662","lindroth.heidi@mayo.edu",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Hannah Friesen","1-507-284-2197","friesen.hannah@mayo.edu",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-92.4699,44.02163,{"lat":37,"lon":36},[40,42,45,48,50,52,54,56],{"name":22,"role":18,"phone":41,"phoneExt":10,"email":24},"507-284-2197",{"name":43,"role":44,"phone":10,"phoneExt":10,"email":10},"Heidi Lindroth, Ph.D., R.N.","PRINCIPAL_INVESTIGATOR",{"name":46,"role":47,"phone":10,"phoneExt":10,"email":10},"Anirban Bhattacharyya, M.D.,M.S","SUB_INVESTIGATOR",{"name":49,"role":47,"phone":10,"phoneExt":10,"email":10},"Arun Jayaraman, M.D,Ph.D",{"name":51,"role":47,"phone":10,"phoneExt":10,"email":10},"Linda Chlan, Ph.D",{"name":53,"role":47,"phone":10,"phoneExt":10,"email":10},"Vitaly Herasevich, M.D.,Ph.D",{"name":55,"role":47,"phone":10,"phoneExt":10,"email":10},"Alejandro Rabinstein, M.D.",{"name":57,"role":47,"phone":10,"phoneExt":10,"email":10},"Malaz Boustani, M.D. M.P.H.",{"type":44,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Heidi L. Lindroth PhD RN","Heidi L. Lindroth, Ph.D., Nurse Scientist, Assistant Professor of Nursing","100529339","automating-delirium-severity-in-the-icu-100529339",false,"NCT06172491","Automating Delirium Severity in the ICU","Harnessing the Power of Technology to Transform Delirium Severity Measurement in the ICU","ADS-ICU","Inclusion Criteria: • Age \\>50;\n\n* Estimated length of stay \\>24 hours in ICU; and\n* Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.\n\nExclusion Criteria:\n\n* Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.\n* Admitted for acute neuronal injury\n* Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)","ALL","50 Years",{"count":72,"type":73},400,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \\>50 years of age.\n\nThe main questions it aims to answer are:\n\n* Is the trained convolutional neural network able to reliably measure delirium severity.\n* Is the Passive Digital Marker able to accurately measure delirium severity\n* Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers).\n\nParticipants will:\n\n* Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU).\n* Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.",[77,78,79],"Intensive Care Unit Delirium","Encephalopathy","Delirium",[79,81,82,83,84],"Severity","Digital marker","Computer Vision","Artificial Intelligence","2026-04-02",{"date":87,"type":88},"2026-04-08","ACTUAL",{"date":90,"type":88},"2023-01-15",{"date":92,"type":73},"2028-05-31",{"name":5,"class":6},1]